多态结构基因组学可实现ABCC6遗传变异的大规模,机械和特定环境分类,这些变异涉及化疾病.
Jessica B Wagenknecht1, Neshatul Haque1, Salomao D Jorge2
1Computational Structural Genomics Unit, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
International journal of molecular sciences
|February 27, 2026
概括
新的ABCC6蛋白3D模型有助于对导致PXE和GACI的遗传变异进行分类. 这种方法重新分类了41%的不确定的变异,改善了对这些化障碍的诊断.
科学领域:
- 基因组学就是基因组学.
- 结构生物学 结构生物学
- 医学遗传学 医学遗传学
背景情况:
- 在ABCC6的遗传变异导致pseudoxanthoma elasticum (PXE) 和婴儿期的一般性动脉化 (GACI).
- 报告的高百分比 (87%) 的ABCC6误解变异具有不确定的临床意义 (VUS),阻碍了诊断和治疗.
- 这些VUS的机械解释和分类需要新的方法.
研究的目的:
- 开发和应用基于结构的方法来解释和分类ABCC6变异的机制.
- 在ABCC6蛋白中识别基于关键结构的功能和热点.
- 为了重新分类VUS并提高ABCC6相关化障碍的诊断准确度.
主要方法:
- 在三种功能相关的形状中开发ABCC6的3D蛋白质模型.
- 应用3D热点检测和ABCC6函数的机械本体学.
- 计算变体的结构效应,并根据受影响的功能对基因组变体进行分类.
主要成果:
- 确定了ABCC6.6的两个3D热点和六个基于关键结构的功能.
- 根据其受影响的功能,针对41%的VUS提出了致病机制.
- 通过基于结构的证据,确定了33种可能被重新归类为可能致病的变种.
结论:
- 基于蛋白质的整体计算方法有助于解释和分类ABCC6变异.
- 这种VUS重新分类策略可以改善PXE,GACI和其他ABCC6相关疾病的诊断.
- 计算结构基因组学对推进基因组数据解释和变异分类具有前景.
关键词:
ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC6ABCC婴儿时期的一般性动脉化.基因组解释 基因组解释精准医学是一门精准医学.伪Xanthoma 弹性 (Elasticum) 是一个假象.变种优先级排名 变种优先级排名相关概念视频
Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Principles of Pharmacogenetics: Types of Genetic Variants
59
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
59
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
607
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
607


